Purpose: To explore which preoperative clinical data and conventional magnetic resonance imaging (MRI) features may indicate the presence of hepatocellular carcinoma (HCC) in HCC patients coexisting with LR-3 and LR-4 lesions.
Methods: HCC Patients coexisting with LR-3 and LR-4 lesions who participated in a prospective clinical trial (XX) were included in this study. Two radiologists independently assessed the preoperative MRI features and each lesion was assigned according to the liver imaging reporting and data system (LI-RADS). The preoperative clinical data were also evaluated. The relative values of these parameters were assessed as potential predictors of HCC for coexisting LR-3 and LR-4 lesions.
Results: We enrolled 102 HCC patients (58.1 ± 11.5 years; 84.3% males) coexisting with 110 LR-3 and LR-4 lesions (HCCs group [n = 66]; non-HCCs group [n = 44]). The presence of restricted diffusion (OR: 18.590, p < 0.001), delayed enhancement (OR: 0.113, p < 0.001), and mild-moderate T2 hyperintensity (OR: 3.084, p = 0.048) were found to be independent predictors of HCC diagnosis. The sensitivity and specificity of the above independent variables for the diagnosis of HCC ranged from 66.7 to 80.3% and 56.8 to 88.6%, respectively. ROC analysis showed that, in discriminating HCC, the AUCs of the above factors were 0.777, 0.686, and 0.670, respectively. Combining these three findings for the prediction of HCC resulted in a specificity greater than 97%, and the AUC further increased to 0.874.
Conclusion: The presence of restricted diffusion, delayed enhancement, and mild-moderate T2 hyperintensity can be useful features for risk stratification of coexisting LR-3 and LR-4 lesions in HCC patients. Trial registration a prospective clinical trial (ChiCTR2000036201).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00261-024-04338-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.
Radiology
December 2024
From the Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 gil, Songpa-Gu, Seoul 05505, Korea (H.J.J., S.H.C., S.J.C., J.H.B., H.J.W., Y.M.S.); University of Ulsan College of Medicine, Seoul, Korea (S.W.); and Liver Imaging Group, Department of Radiology, University of California- San Diego, San Diego, Calif (C.B.S.).
Background Prediction of the tumor growth rates is clinically important in patients with hepatocellular carcinoma (HCC), but previous studies have presented conflicting results and generally lacked radiologic evaluations. Purpose To evaluate the percentage of rapidly growing early-stage HCCs in each Liver Imaging Reporting and Data System (LI-RADS) category and to identify prognostic factors associated with rapid growth. Materials and Methods Retrospective study of patients with risk factors for HCC and those with surgically proven early-stage HCC who underwent two or more preoperative multiphasic CT or MRI examinations between January 2016 and December 2020.
View Article and Find Full Text PDFCombining CEUS and CT/MRI LI-RADS major imaging features: diagnostic accuracy for classification of indeterminate liver observations in patients at risk for HCC.
Abdom Radiol (NY)
October 2024
Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, USA.
Purpose: To determine the diagnostic accuracy of combining CEUS and CT/MRI LI-RADS major imaging features for the improved categorization of liver observations indeterminate on both CT/MRI and CEUS.
Materials And Methods: A retrospective analysis using a database from a prospective study conducted at 11 centers in North America and Europe from 2018 to 2022 included a total of 109 participants at risk for HCC who had liver observations with indeterminate characterization (LR3, LR-4, and LR-M) on both CEUS and CT/MRI. The individual CEUS and CT/MRI LI-RADS major features were extracted from the original study and analyzed in various combinations.
Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic hepatitis C virus infection.
Abdom Radiol (NY)
September 2024
Stanford University, Stanford, USA.
Article Synopsis
- The study aims to evaluate how well LI-RADS (Liver Imaging Reporting and Data System) diagnoses liver cancer in patients with non-cirrhotic HCV infection, analyzing data from 66 observations involving adult patients.
- Results show that while LI-RADS categories like LR-1 and LR-2 had no predictive value, LR-5 demonstrated high sensitivity (74-90%) and specificity (94-100%) for hepatic cellular carcinoma (HCC), making it a reliable indicator.
- The inter-reader agreement among radiologists was substantial for final assessments, suggesting that LI-RADS can be effectively used for diagnosing malignancies in this patient group with excellent specificity.
Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysis.
Abdom Radiol (NY)
September 2024
Duke University School of Medicine, Durham, NC, USA.
Article Synopsis
- The study evaluates how the presence of concurrent LR-5 observations impacts the likelihood that LR-3 or LR-4 observations indicate hepatocellular carcinoma (HCC), using a meta-analysis approach.
- The research analyzed data from 29 studies involving 2,591 observations across 1,456 patients, examining the predictive values of LR-3 and LR-4 with and without concurrent LR-5 observations.
- Results showed no significant difference in the positive predictive value for LR-3 and LR-4 observations whether concurrent LR-5 was present or not, suggesting that the presence of LR-5 does not substantially affect HCC diagnosis.
CEUS LI-RADS in Combination With the Serum Biomarker-Based ASAP Model Improves the Diagnostic Performance of HCC in High-Risk Patients.
Ultrasound Med Biol
November 2024
Department of Medical Ultrasound, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Electronic address:
Article Synopsis
- The study aimed to evaluate how effective the CEUS LI-RADS system is for diagnosing hepatocellular carcinoma (HCC) in high-risk patients when combined with the ASAP model based on age, sex, AFP, and PIVKA-II levels.
- Researchers analyzed 366 liver lesions and applied specific criteria to enhance the classification of uncertain lesions to a definitive diagnosis of HCC.
- The results showed that using the ASAP model significantly increased diagnostic sensitivity of LR-5 to 86.9%, while maintaining high specificity and positive predictive value, suggesting this approach benefits HCC diagnosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!